LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States.

    de Havenon, Adam / Ney, John P / Callaghan, Brian / Delic, Alen / Hohmann, Samuel / Shippey, Ernie / Esper, Gregory J / Stulberg, Eric / Tirschwell, David / Frontera, Jennifer / Yaghi, Shadi / Anadani, Mohammad / Majersik, Jennifer J

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

    2020  Volume 30, Issue 2, Page(s) 105535

    Abstract: ... weighted OR 0.63, 95% CI 0.54-0.73).: Conclusions: Ischemic stroke patients with COVID-19 are more ... Background: Studies have shown worse outcomes in patients with comorbid ischemic stroke (IS) and ... compared to both ischemic stroke controls from 2019 and to patients with ischemic stroke and pneumonia. ...

    Abstract Background: Studies have shown worse outcomes in patients with comorbid ischemic stroke (IS) and coronavirus disease 2019 (COVID-19), but have had small sample sizes.
    Methods: We retrospectively identified patients in the Vizient Clinical Data Base® with IS as a discharge diagnosis. The study outcomes were in-hospital death and favorable discharge (home or acute rehabilitation). In the primary analysis, we compared IS patients with laboratory-confirmed COVID-19 (IS-COVID) discharged April 1-July 31, 2020 to pre-COVID IS patients discharged in 2019 (IS controls). In a secondary analysis, we compared a matched cohort of IS-COVID patients to patients within the IS controls who had pneumonia (IS-PNA), created with inverse-probability-weighting (IPW).
    Results: In the primary analysis, we included 166,586 IS controls and 2086 IS-COVID from 312 hospitals in 46 states. Compared to IS controls, IS-COVID were less likely to have hypertension, dyslipidemia, or be smokers, but more likely to be male, younger, have diabetes, obesity, acute renal failure, acute coronary syndrome, venous thromboembolism, intubation, and comorbid intracerebral or subarachnoid hemorrhage (all p<0.05). Black and Hispanic patients accounted for 21.7% and 7.4% of IS controls, respectively, but 33.7% and 18.5% of IS-COVID (p<0.001). IS-COVID, versus IS controls, were less likely to receive alteplase (1.8% vs 5.6%, p<0.001), mechanical thrombectomy (4.4% vs. 6.7%, p<0.001), to have favorable discharge (33.9% vs. 66.4%, p<0.001), but more likely to die (30.4% vs. 6.5%, p<0.001). In the matched cohort of patients with IS-COVID and IS-PNA, IS-COVID had a higher risk of death (IPW-weighted OR 1.56, 95% CI 1.33-1.82) and lower odds of favorable discharge (IPW-weighted OR 0.63, 95% CI 0.54-0.73).
    Conclusions: Ischemic stroke patients with COVID-19 are more likely to be male, younger, and Black or Hispanic, with significant increases in morbidity and mortality compared to both ischemic stroke controls from 2019 and to patients with ischemic stroke and pneumonia.
    MeSH term(s) Adolescent ; Adult ; Age Factors ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/mortality ; COVID-19/therapy ; Comorbidity ; Databases, Factual ; Female ; Hospital Mortality ; Humans ; Ischemic Stroke/diagnosis ; Ischemic Stroke/epidemiology ; Ischemic Stroke/mortality ; Ischemic Stroke/therapy ; Male ; Middle Aged ; Patient Discharge ; Race Factors ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sex Factors ; Time Factors ; Treatment Outcome ; United States ; Young Adult
    Language English
    Publishing date 2020-12-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1131675-5
    ISSN 1532-8511 ; 1052-3057
    ISSN (online) 1532-8511
    ISSN 1052-3057
    DOI 10.1016/j.jstrokecerebrovasdis.2020.105535
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The impact of the COVID-19 pandemic on cerebrovascular disease.

    Bass, David I / Meyer, R Michael / Barros, Guilherme / Carroll, Kate T / Walker, Melanie / D'Oria, Mario / Levitt, Michael R

    Seminars in vascular surgery

    2021  Volume 34, Issue 2, Page(s) 20–27

    Abstract: ... of in-hospital mortality than patients with either acute ischemic stroke or COVID-19 alone. ... and whether ischemic stroke is a clinical feature specific to COVID-19 pathophysiology. Early reports ... treatment, and outcomes to better understand the impact of COVID-19 on cerebrovascular disease. Much ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a systemic disease that affects nearly all organ systems through infection and subsequent dysregulation of the vascular endothelium. One of the most striking phenomena has been a coronavirus disease 2019 (COVID-19)-associated coagulopathy. Given these findings, questions naturally emerged about the prothrombotic impact of COVID-19 on cerebrovascular disease and whether ischemic stroke is a clinical feature specific to COVID-19 pathophysiology. Early reports from China and several sites in the northeastern United States seemed to confirm these suspicions. Since these initial reports, many cohort studies worldwide observed decreased rates of stroke since the start of the pandemic, raising concerns for a broader impact of the pandemic on stroke treatment. In this review, we provide a comprehensive assessment of how the pandemic has affected stroke presentation, epidemiology, treatment, and outcomes to better understand the impact of COVID-19 on cerebrovascular disease. Much evidence suggests that this decline in stroke admissions stems from the global response to the virus, which has made it more difficult for patients to get to the hospital once symptoms start. However, there does not appear to be a demonstrable impact on quality metrics once patients arrive at the hospital. Despite initial concerns, there is insufficient evidence to ascribe a causal relationship specific to the pathogenicity of SARS-CoV-2 on the cerebral vasculature. Nevertheless, when patients infected with SARS-CoV-2 present with stroke, their presentation is likely to be more severe, and they have a markedly higher rate of in-hospital mortality than patients with either acute ischemic stroke or COVID-19 alone.
    MeSH term(s) COVID-19/complications ; COVID-19/diagnosis ; COVID-19/therapy ; Cerebrovascular Disorders/epidemiology ; Cerebrovascular Disorders/therapy ; Cerebrovascular Disorders/virology ; Humans
    Language English
    Publishing date 2021-05-20
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645131-7
    ISSN 1558-4518 ; 0895-7967
    ISSN (online) 1558-4518
    ISSN 0895-7967
    DOI 10.1053/j.semvascsurg.2021.05.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?

    Hajdu, Steven D / Pittet, Valerie / Puccinelli, Francesco / Ben Hassen, Wagih / Ben Maacha, Malek / Blanc, Raphaël / Bracco, Sandra / Broocks, Gabriel / Bartolini, Bruno / Casseri, Tommaso / Clarençon, Frederic / Naggara, Olivier / Eugène, François / Ferré, Jean-Christophe / Guédon, Alexis / Houdart, Emmanuel / Krings, Timo / Lehmann, Pierre / Limbucci, Nicola /
    Machi, Paolo / Macho, Juan / Mandruzzato, Nicolo / Nappini, Sergio / Nawka, Marie Teresa / Nicholson, Patrick / Marto, João Pedro / Pereira, Vitor / Correia, Manuel A / Pinho-E-Melo, Teresa / Nuno Ramos, João / Raz, Eytan / Ferreira, Patrícia / Reis, João / Shapiro, Maksim / Shotar, Eimad / van Horn, Noel / Piotin, Michel / Saliou, Guillaume

    Stroke

    2020  Volume 51, Issue 8, Page(s) 2593–2596

    Abstract: ... the effect on EVT for patients with acute ischemic stroke during the COVID-19 confinement ... included 1600 patients treated by EVT for acute ischemic stroke. Date of EVT and symptom onset-to-groin ... treatments for acute ischemic stroke due to large vessel occlusion. The purpose of our study was to determine ...

    Abstract During the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization recommended measures to mitigate the outbreak such as social distancing and confinement. Since these measures have been put in place, anecdotal reports describe a decrease in the number of endovascular therapy (EVT) treatments for acute ischemic stroke due to large vessel occlusion. The purpose of our study was to determine the effect on EVT for patients with acute ischemic stroke during the COVID-19 confinement. In this retrospective, observational study, data were collected from November 1, 2019, to April 15, 2020, at 17 stroke centers in countries where confinement measures have been in place since March 2020 for the COVID-19 pandemic (Switzerland, Italy, France, Spain, Portugal, Germany, Canada, and United States). This study included 1600 patients treated by EVT for acute ischemic stroke. Date of EVT and symptom onset-to-groin puncture time were collected. Mean number of EVTs performed per hospital per 2-week interval and mean stroke onset-to-groin puncture time were calculated before confinement measures and after confinement measures. Distributions (non-normal) between the 2 groups (before COVID-19 confinement versus after COVID-19 confinement) were compared using 2-sample Wilcoxon rank-sum test. The results show a significant decrease in mean number of EVTs performed per hospital per 2-week interval between before COVID-19 confinement (9.0 [95% CI, 7.8-10.1]) and after COVID-19 confinement (6.1 [95% CI, 4.5-7.7]), (
    MeSH term(s) Brain Ischemia/therapy ; COVID-19 ; Coronavirus Infections ; Disease Management ; Eligibility Determination ; Endovascular Procedures/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral ; Quarantine ; Retrospective Studies ; Spain ; Stroke/therapy ; Time-to-Treatment ; Treatment Outcome
    Keywords covid19
    Language English
    Publishing date 2020-07-01
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.120.030794
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Acute Stroke Management During the COVID-19 Pandemic

    Hajdu, S.D. / Pittet, V. / Puccinelli, F. / Ben Hassen, W. / Ben Maacha, M. / Blanc, R. / Bracco, S. / Broocks, G. / Bartolini, B. / Casseri, T. / Clarençon, F. / Naggara, O. / Eugène, F. / Ferré, J.C. / Guédon, A. / Houdart, E. / Krings, T. / Lehmann, P. / Limbucci, N. /
    Machi, P. / Macho, J. / Mandruzzato, N. / Nappini, S. / Nawka, M.T. / Nicholson, P. / Marto, J.P. / Pereira, V. / Correia, M.A. / Pinho-E-Melo, T. / Nuno Ramos, J. / Raz, E. / Ferreira, P. / Reis, J. / Shapiro, M. / Shotar, E. / van Horn, N. / Piotin, M. / Saliou, G.

    Stroke, vol. 51, no. 8, pp. 2593-2596

    Does Confinement Impact Eligibility for Endovascular Therapy?

    2020  

    Abstract: ... the effect on EVT for patients with acute ischemic stroke during the COVID-19 confinement ... included 1600 patients treated by EVT for acute ischemic stroke. Date of EVT and symptom onset-to-groin ... treatments for acute ischemic stroke due to large vessel occlusion. The purpose of our study was to determine ...

    Abstract During the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization recommended measures to mitigate the outbreak such as social distancing and confinement. Since these measures have been put in place, anecdotal reports describe a decrease in the number of endovascular therapy (EVT) treatments for acute ischemic stroke due to large vessel occlusion. The purpose of our study was to determine the effect on EVT for patients with acute ischemic stroke during the COVID-19 confinement. In this retrospective, observational study, data were collected from November 1, 2019, to April 15, 2020, at 17 stroke centers in countries where confinement measures have been in place since March 2020 for the COVID-19 pandemic (Switzerland, Italy, France, Spain, Portugal, Germany, Canada, and United States). This study included 1600 patients treated by EVT for acute ischemic stroke. Date of EVT and symptom onset-to-groin puncture time were collected. Mean number of EVTs performed per hospital per 2-week interval and mean stroke onset-to-groin puncture time were calculated before confinement measures and after confinement measures. Distributions (non-normal) between the 2 groups (before COVID-19 confinement versus after COVID-19 confinement) were compared using 2-sample Wilcoxon rank-sum test. The results show a significant decrease in mean number of EVTs performed per hospital per 2-week interval between before COVID-19 confinement (9.0 [95% CI, 7.8-10.1]) and after COVID-19 confinement (6.1 [95% CI, 4.5-7.7]), (P<0.001). In addition, there is a significant increase in mean stroke onset-to-groin puncture time (P<0.001), between before COVID-19 confinement (300.3 minutes [95% CI, 285.3-315.4]) and after COVID-19 confinement (354.5 minutes [95% CI, 316.2-392.7]). Our preliminary analysis indicates a 32% reduction in EVT procedures and an estimated 54-minute increase in symptom onset-to-groin puncture time after confinement measures for COVID-19 pandemic were put into place.
    Keywords Brain Ischemia/therapy ; Coronavirus Infections ; Disease Management ; Eligibility Determination ; Endovascular Procedures/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia ; Viral ; Quarantine ; Retrospective Studies ; Spain ; Stroke/therapy ; Time-to-Treatment ; Treatment Outcome ; COVID-19 ; goal ; groin ; pandemic ; standard of care ; covid19
    Subject code 616
    Language English
    Publishing country ch
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top